Feature image

What's New

COVID-19 vaccine safety monitoring and reporting

Medsafe is publishing information weekly on the number of reports of adverse events following immunisation with COVID-19 vaccines.

Go to safety reports

News and Events

Date Type Title
12/05/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #6 – 10 April 2021
5/05/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #5 – 3 April 2021
29/04/2021NoticesUnapproved COVID-19 vaccines - restriction on importation, manufacture, supply and use
29/04/2021Alert CommunicationFluad Quad - a newly funded influenza vaccine for people aged 65 years and older
28/04/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #4 – 27 March 2021
27/04/2021Monitoring CommunicationCOVID-19 vaccines and rare cases of blood clots with bleeding: no current risk with Comirnaty (Pfizer/ BioNTech) vaccine
23/04/2021CommitteesComments on agenda items for the 66th meeting of the Medicines Classification Committee to be held on 11 May 2021
22/04/2021NoticesAdverse Drug Reaction Reporting Statistics - 2020
21/04/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #3 – 20 March 2021
14/04/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #2 – 13 March 2021
13/04/2021CommitteesMedicines Adverse Reactions Committee - Minutes of 185th meeting - 11 March 2021
12/04/2021ConsultationOutcome of the consultation on the Plan to update the New Zealand Code of Good Manufacturing Practice PIC/S Guide PE009-8 to PE009-14
9/04/2021CommitteesAgenda for the 110th meeting of the Medicines Assessment Advisory Committee - 13 April 2021
7/04/2021Monitoring CommunicationUpdate - Possible risk of psoriasis exacerbation with bupropion
7/04/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #1 – 6 March 2021
1/04/2021NoticesInfluenza Vaccine Adverse Drug Reaction Reporting Statistics
29/03/2021ConsultationOutcome of the consultation on the proposed changes to paracetamol warning and advisory statements
23/03/2021Alert CommunicationUPDATE: Concern reported with the use of NovoRapid®Penfill® (insulin aspart; 3 mL cartridge) by type 1 diabetes patients
16/03/2021Alert CommunicationUPDATE - Rocuronium bromide solution for injection 10mg/mL, Hameln, and reports of lack of efficacy